Alert: October 13, 2009

Raising My Target

UPDATE: One of our holdings blasted through our target today and is still on the rise. So should we sell?
Continue Reading

Alert: September 18, 2009

Do-It-Yourself Profits

BUY: This financial publisher's research and opinion is well-suited for the individual investor that wants to beat Wall Street at its own game.
Continue Reading

Alert: September 3, 2009

Lock in Your 200%-Plus Profits

SELL: On the heels of my recommendation and unrelated speculation the stock rocketed over 200%.
Continue Reading

Alert: August 28, 2009

My Next Double

BUY: Momentum and a short squeeze could drive these mortgage stocks to a double after Labor Day.
Continue Reading

Alert: July 29, 2009

Hearty Profits

BUY: This company is a prime takeover candidate with a breakthrough treatment for chronic heart failure. Meanwhile our last biotech trade has risen 40% since my recommendation.
Continue Reading

Alert: July 23, 2009

Time to Move On

SELL: It's time to let our solar stock go.
BUY: Meanwhile, a pioneer in diabetes treatment may be a takeover candidate, and second-quarter earnings indicate a new growth cycle will restore this trucker's former glory.
Continue Reading

  • 2009 October
    • Raising My Target October 13, 2009

      One of our holdings blasted through our target today and is still on the rise. So should we sell?

  • 2009 September
    • Do-It-Yourself Profits September 18, 2009

      This financial publisher's research and opinion is well-suited for the individual investor that wants to beat Wall Street at its own game.

    • Lock in Your 200%-Plus Profits September 3, 2009

      On the heels of my recommendation and unrelated speculation the stock rocketed over 200%.

  • 2009 August
    • My Next Double August 28, 2009

      Momentum and a short squeeze could drive these mortgage stocks to a double after Labor Day.

  • 2009 July
    • Hearty Profits July 29, 2009

      This company is a prime takeover candidate with a breakthrough treatment for chronic heart failure. Meanwhile our last biotech trade has risen 40% since my recommendation.

    • Time to Move On July 23, 2009

      It's time to let our solar stock go.
      BUY: Meanwhile, a pioneer in diabetes treatment may be a takeover candidate, and second-quarter earnings indicate a new growth cycle will restore this trucker's former glory.

    • Bank With a Backstop July 16, 2009

      A $300 million capital injection and a billion shares of new common stock mean this bank is set to double.

    • Two Short-Term Trades July 9, 2009

      Short-term catalysts can bring us big gains in a back-to-school retail winner and an alternative energy company.

  • 2009 June